Bristol-Myers Squibb (BMY) Declares $0.37 Quarterly Dividend; 2.4% Yield

Go back to Bristol-Myers Squibb (BMY) Declares $0.37 Quarterly Dividend; 2.4% Yield

BMO Positive on Bristol-Myers Squibb's (BMY) Receipt of FDA Breakthrough Therapy Designation for Opdivo

September 16, 2015 2:07 PM EDT

BMO Capital affirms its Outperform rating and $74 price target on Bristol-Myers Squibb Company (NYSE: BMY) after BMY... More